All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2004-001290-25||: Estudio multicéntrico, abierto, aleatorizado, de 3 años de seguimiento, que compara micofenolato sódico con recubrimiento entérico de novo con everolimus de inicio retrasado, ambos grupos en combina...||2011-12-31||due-trials|
|Ongoing||2004-004691-37||Etanercept in Psoriasis and Psoriatic Arthritis: a single center, open-label study in 15 patients.||not-yet-due|
|Ongoing||2006-006692-20||The TOMIBA study Treatment of Osteoporotic Men With Intravenous Ibandronate An open-label, single-center, prospective Phase III study||not-yet-due|
|Not reported||2009-017525-19||Abatacept in Psoriasis and Psoriatic Arthritis: a single centre, placebo-controlled, crossover study in 15 patients.||2014-08-11||due-trials|
|Reported results||2011-002561-38||A double blind, randomized, placebo controlled, crossover study of the effectiveness of oral fampridine in improving upper limb function in progressive multiple sclerosis.||2016-02-16||due-trials|
|Ongoing||2016-001785-29||Combined Effect of CFTR Modifiers and Intensive Antibiotic Treatment||not-yet-due|